FDA Approves First RSV Vaccine for Pregnancy FDA Approves First RSV Vaccine for Pregnancy
The vaccine can be given after 32 weeks of pregnancy and is designed to protect infants from respiratory syncytial virus from birth to 6 months of age.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Alert Source Type: news
More News: Allergy | Allergy & Immunology | Infectious Diseases | Pregnancy | Respiratory Medicine | Vaccines